Polar Capital Healthcare Opportunities breaches 10% exposure limit after Danish pharma firm soars
The Polar Capital Healthcare Opportunities fund has breached the 10% holding limit for UCITS funds, as its top holding swelled to more than 12%.
Stay updated with breaking news from Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Polar Capital Healthcare Opportunities fund has breached the 10% holding limit for UCITS funds, as its top holding swelled to more than 12%.
Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's...
/PRNewswire/ -- (OTC Pink: CETI), Cyber Enviro-Tech, Inc. (CETI) is pleased to announce it is filing a formal application to upgrade its trading platform from...
Agri-Pulse is a trusted source in Washington, D.C., with the largest editorial team focused on food, fuel, fiber and farm policy coverage. Agri-Pulse presents a balanced perspective on a wide variety of issues.
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043...